Cetirizine Hydrochloride And Pseudoephedrine Hydrochloride Tablet, Film Coated, Extended Release
Product Images NDC 62756-915

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Cetirizine Hydrochloride And Pseudoephedrine Hydrochloride (NDC 62756-915). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sun Pharmaceutical Industries, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Spl Cetiri Pseu

This is a drug information sheet for Cetirizine Hydrochloride and Pseudoephedrine Hydrochloride Extended-release Tablets, USP, an antihistamine/nasal decongestant. It describes how the medicine can help to temporarily relieve symptoms such as runny nose, sneezing, and itchy, watery eyes due to hay fever or other upper respiratory allergies. The sheet includes instructions on how to use the medicine for adults and children, as well as advice on what to do if you have certain health conditions. There are also warnings about potential side effects of using the product, and a list of inactive ingredients.*

FDA Label Image

Spl-cetirizine-pseudoephedrine-blister (Spl Cetirizine Pseudoephedrine Blister)

This is the label of a medicine box showing product details such as name, manufacturer, dosage, and ingredients. The medicine is an extended-release tablet containing Cetirizine Hydrochloride (5 mg) and Pseudoephedrine Hydrochloride (120 mg). It is manufactured by Sun Pharmaceutical Ind. Ltd. India.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.